about
Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brainHigh dietary lipid level is associated with persistent hyperglycaemia and downregulation of muscle Akt-mTOR pathway in Senegalese sole (Solea senegalensis).Clustering of transcriptional profiles identifies changes to insulin signaling as an early event in a mouse model of Alzheimer's disease.Melatonin Therapy in Patients with Alzheimer's Disease.How predictive of dementia are peripheral inflammatory markers in the elderly?Reduced Incidence of Dementia in Solid Organ Transplant Patients Treated with Calcineurin InhibitorsAlzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylaseFasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies.Adipose tissue inflammation in glucose metabolism.IV. The cognitive implications of obesity and nutrition in childhood.Neprilysin facilitates adipogenesis through potentiation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway.Physical activity and hippocampal volume in middle-aged patients with type 1 diabetes."Weighing" the effects of exercise and intrinsic aerobic capacity: are there beneficial effects independent of changes in weight?Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal.Impact of Physical Activity on Cognitive Decline, Dementia, and Its Subtypes: Meta-Analysis of Prospective StudiesBiological and biophysics aspects of metformin-induced effects: cortex mitochondrial dysfunction and promotion of toxic amyloid pre-fibrillar aggregates.The role of melatonin in the onset and progression of type 3 diabetes.Obesity as a risk factor for Alzheimer's disease: weighing the evidence.Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease.Examining the Relationship between Trace Lithium in Drinking Water and the Rising Rates of Age-Adjusted Alzheimer's Disease Mortality in Texas.Leptin-deficient obesity prolongs survival in a murine model of myelodysplastic syndrome.
P2860
Q27003253-E2153716-C98A-4ECF-9482-BD2525A563BDQ33921401-EE32F72B-E65E-4F2C-92DF-51F73C0811EDQ35052443-8FEED598-CCD7-4CA4-906C-25C7D83D861EQ36335048-DD600E9D-8B8C-472C-BC82-72F939F24D5AQ36630566-07F547A4-8D9E-44A5-9CFB-C9DC219202C1Q37044162-CB900B68-57C4-4915-98F9-47780760A377Q37212345-1DFB549C-3E79-4512-B314-D1086CD0A689Q37318393-7FCA72D8-B897-476D-84BE-91612C78596FQ38139293-F4A67FEC-5443-436D-98A1-510E5CA243FCQ38267164-02CF807B-D355-41B2-AE4B-171B58F3F7E6Q38714743-4A5FAE70-FAF9-4967-9702-2CB697F5EDB4Q38914029-D0E0F9E6-99E2-4D2B-9B13-672C73757420Q38924578-B827EE0E-1822-49B6-8795-092567BB325AQ38938961-C5BB4A0E-2E4A-40AF-AAA9-7EDA97EB9175Q39167358-6141A5AB-70A4-49EB-9895-EC653CAEC92AQ41152081-C1D9349F-E740-48E9-B201-F97DA7BFF08FQ41206619-A68F0023-7A7D-4087-B597-9763B626AC14Q41986529-FAB70361-D794-438D-B2E3-7934065039D1Q41995767-A31A0133-CDAC-46F2-AC04-E8BFB7DA125BQ47657930-8EB6BB11-3770-403C-A034-C9B98430E823Q49681927-F4948FD2-DF17-44AE-B2FF-F7E6CB0027D6
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Obesity, insulin resistance, and Alzheimer's disease.
@en
type
label
Obesity, insulin resistance, and Alzheimer's disease.
@en
prefLabel
Obesity, insulin resistance, and Alzheimer's disease.
@en
P2860
P356
P1433
P1476
Obesity, insulin resistance, and Alzheimer's disease.
@en
P2093
Kerry L Hildreth
Robert S Schwartz
P2860
P304
P356
10.1038/OBY.2012.19
P577
2012-02-07T00:00:00Z